<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Pfizer Is A Fallen Angel? Beat Those Wings, Jeff</title>
	<atom:link href="http://www.pharmalot.com/2008/07/pfizer-is-a-fallen-angel-beat-those-wings-jeff/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/07/pfizer-is-a-fallen-angel-beat-those-wings-jeff/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 20:47:41 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Stinky</title>
		<link>http://www.pharmalot.com/2008/07/pfizer-is-a-fallen-angel-beat-those-wings-jeff/#comment-368226</link>
		<dc:creator>Stinky</dc:creator>
		<pubDate>Thu, 31 Jul 2008 02:37:39 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14876#comment-368226</guid>
		<description>A whole lot of ifs in the BW article.  Stock price estimates should not be based on speculation as to whether a merger or new product will magically happen.  The problem is that Pfizer's current pipeline is running dry, and there is nothing on the horizon that can replace Lipitor.  As far as strategic acquisitions pushing the company stock price up, that is unlikely for at least two reasons.  1 - When a company buys the another, that typically pushes the stock price of the larger company down and the price of the acquired company up.  2 - Pfizers track record for acquisitions hasn't been all that great.  They are still working out many kinks from their old deals.  
Pfizer puff piece.</description>
		<content:encoded><![CDATA[<p>A whole lot of ifs in the BW article.  Stock price estimates should not be based on speculation as to whether a merger or new product will magically happen.  The problem is that Pfizer&#8217;s current pipeline is running dry, and there is nothing on the horizon that can replace Lipitor.  As far as strategic acquisitions pushing the company stock price up, that is unlikely for at least two reasons.  1 - When a company buys the another, that typically pushes the stock price of the larger company down and the price of the acquired company up.  2 - Pfizers track record for acquisitions hasn&#8217;t been all that great.  They are still working out many kinks from their old deals.<br />
Pfizer puff piece.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Justice in MI</title>
		<link>http://www.pharmalot.com/2008/07/pfizer-is-a-fallen-angel-beat-those-wings-jeff/#comment-368196</link>
		<dc:creator>Justice in MI</dc:creator>
		<pubDate>Wed, 30 Jul 2008 20:07:06 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=14876#comment-368196</guid>
		<description>Those of us who follow the roller-coaster approach to investing see the graphic as a good-looking curve.  But what if it was the view from the perspective of one year, three years, five years?  (I have no idea - haven't looked it up).  

But that's how we in the roller-coaster school distinguish between a blip and a burp.  I have a feeling BizWeek does it differently.</description>
		<content:encoded><![CDATA[<p>Those of us who follow the roller-coaster approach to investing see the graphic as a good-looking curve.  But what if it was the view from the perspective of one year, three years, five years?  (I have no idea - haven&#8217;t looked it up).  </p>
<p>But that&#8217;s how we in the roller-coaster school distinguish between a blip and a burp.  I have a feeling BizWeek does it differently.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.147 seconds -->

